Sébastien Gallice : “It’s a great curiosity that arises about new concepts”
Find the interview of Sébastien Gallice, president of PREF and pharmacist in one of the largest preparatory pharmacies in France.
News en
MB Therapeutics receives the French Tech Emergence Grant
The Public Investment Bank grants MB Therapeutics a subsidy for the development of next-generation drugs.
MB Therapeutics expands its team with the arrival of Léna Lemierre, an expert in pharmaceutical 3D printing
Discover how Léna Lemierre, an expert in pharmaceutical 3D printing, is accelerating the development of personalized medicine.
The regional fund Créalia is providing support to MB Therapeutics
The seed fund Créalia awards an innovation grant to MB Therapeutics for the development of its personalized medicine solution.
MB Therapeutics is labeled as a deep tech company
MB Therapeutics has obtained the Deeptech label from BPI for a personalized medicine manufacturing project using 3D printing.